Better Coronavirus Stock: AstraZeneca or Moderna?

Better Coronavirus Stock: AstraZeneca or Moderna?

Moderna has been a much bigger winner than AstraZeneca year to date. Probably the best argument for buying AstraZeneca instead of Moderna is that it's less risky. AstraZeneca, on the other hand, can more readily absorb any setbacks because of its diversified portfolio.